HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,650,000
- Total 13F shares
- 128,337,653
- Share change
- -1,053,464
- Total reported value
- $5,115,592,058
- Put/Call ratio
- 20%
- Price per share
- $39.88
- Number of holders
- 298
- Value change
- -$42,336,732
- Number of buys
- 129
- Number of sells
- 156
Quarterly Holders Quick Answers
What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40637H109:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
16%
|
19,439,863
|
$781,676,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
13,495,913
|
$542,670,000 | — | 31 Dec 2021 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
7.7%
|
9,505,768
|
$382,227,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
5,860,832
|
$235,664,000 | — | 31 Dec 2021 | |
| Invesco Ltd. |
13F
|
Company |
4.5%
|
5,506,233
|
$221,406,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
4.1%
|
5,126,301
|
$206,129,000 | — | 31 Dec 2021 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
4.1%
|
5,073,665
|
$204,012,000 | — | 31 Dec 2021 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
3.3%
|
4,064,779
|
$163,445,000 | — | 31 Dec 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.5%
|
3,072,956
|
$123,564,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.2%
|
2,765,247
|
$111,191,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
2,474,566
|
$99,502,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.9%
|
2,300,973
|
$92,522,000 | — | 31 Dec 2021 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.6%
|
1,927,738
|
$77,514,000 | — | 31 Dec 2021 | |
| Swedbank AB |
13F
|
Company |
1.5%
|
1,820,000
|
$73,382,400 | — | 31 Dec 2021 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.3%
|
1,558,644
|
$62,673,000 | — | 31 Dec 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
1,554,544
|
$62,508,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.2%
|
1,540,266
|
$61,936,000 | — | 31 Dec 2021 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.2%
|
1,511,843
|
$60,791,000 | — | 31 Dec 2021 | |
| TRAN CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.2%
|
1,499,576
|
$60,298,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
1,294,615
|
$52,057,000 | — | 31 Dec 2021 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
1%
|
1,274,679
|
$51,255,000 | — | 31 Dec 2021 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
1%
|
1,256,542
|
$50,663,000 | — | 31 Dec 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
1%
|
1,259,450
|
$50,642,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.92%
|
1,138,363
|
$45,774,000 | — | 31 Dec 2021 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.87%
|
1,076,833
|
$43,300,000 | — | 31 Dec 2021 | |
| Bellevue Group AG |
13F
|
Company |
0.86%
|
1,067,500
|
$42,924,000 | — | 31 Dec 2021 | |
| NORGES BANK |
13F
|
Company |
0.85%
|
1,046,198
|
$42,068,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.78%
|
970,318
|
$39,016,000 | — | 31 Dec 2021 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.76%
|
942,730
|
$37,907,000 | — | 31 Dec 2021 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.76%
|
934,562
|
$37,579,000 | — | 31 Dec 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.75%
|
930,451
|
$37,413,000 | — | 31 Dec 2021 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.72%
|
889,937
|
$35,784,000 | — | 31 Dec 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.7%
|
864,173
|
$34,748,000 | — | 31 Dec 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.57%
|
705,079
|
$28,352,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
0.55%
|
683,039
|
$27,464,000 | — | 31 Dec 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.54%
|
671,571
|
$27,004,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.53%
|
653,857
|
$26,292,000 | — | 31 Dec 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.51%
|
631,127
|
$25,376,000 | — | 31 Dec 2021 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.47%
|
586,274
|
$23,575,000 | — | 31 Dec 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.47%
|
584,910
|
$23,519,000 | — | 31 Dec 2021 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.44%
|
546,715
|
$21,983,000 | — | 31 Dec 2021 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.44%
|
539,742
|
$21,703,000 | — | 31 Dec 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.41%
|
509,907
|
$20,504,000 | — | 31 Dec 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.4%
|
492,521
|
$19,805,000 | — | 31 Dec 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.39%
|
481,235
|
$19,350,000 | — | 31 Dec 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.36%
|
443,653
|
$17,856,000 | — | 31 Dec 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.34%
|
415,414
|
$16,704,000 | — | 31 Dec 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.32%
|
392,000
|
$15,762,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
373,637
|
$15,025,000 | — | 31 Dec 2021 | |
| Redwood Investments, LLC |
13F
|
Company |
0.3%
|
366,897
|
$14,753,000 | — | 31 Dec 2021 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q1 2022
As of 31 Mar 2022,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
298 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
128,337,653 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Artisan Partners Limited Partnership, STATE STREET CORP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Invesco Ltd., JPMORGAN CHASE & CO, SNYDER CAPITAL MANAGEMENT L P, GEODE CAPITAL MANAGEMENT, LLC, and MACQUARIE GROUP LTD.
This page lists
299
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
314
Q1 2022 holders
298
Holder diff
-16
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.